Many doctors and researchers dedicate their lives to just one field of research. One renowned Oncologist, however, is making his name known for research in both cancer and anti-aging research. For Dr. Mikhail Blagosklonny, working on treatments for both cancer and the effects of aging is a passion that has spanned for decades.
Dr. Blagosklonny’s research into both cancer and anti-aging can be traced back to his work with the cancer treatment drug Rapamycin. Also known as Sirolimus, this drug is used to help prevent organ transplant rejection. Further research by Dr. Blagosklonny has shown that Rapamycin has incredible immunosuppressive and antiproliferative properties that can be used in anti-aging treatment. Read Mikhail’s plans for Oncology on Healingmagic.net.
Dr. Blagosklonny’s research has shown that Rapamycin can be a useful treatment in the field of anti-aging and has advocated for the wider use of the drug. The Oncologist tested the drug on aging mice and found that the mice were able to deal with diseases such as tuberculosis.
Human tests on Rapamycin revealed immunological rejuvenation on a set of elderly patients. The drug was given to the patients before they received an influenza vaccination. While there is not yet conclusive proof that Rapamycin can increase human longevity, Dr. Blagosklonny advocates continuing research of the drug on a wide group of human test subjects.
Mikhail Blagosklonny’s research centers around his belief that cancer and anti-aging are both intertwined. And by using cancer drugs to treat aging, the population can see an overall increase in lifespan while seeing a decrease in cancer rates.
Learn more: https://classroomvoices.org/understanding-oncology-through-mikhail-blagosklonny/
This is what makes Rapamycin a big focus of Mikhail Blagosklonny’s research. The drug is one of the only known that can both fight cancer and aging. Some of the other impacts of Rapamycin on the human body include immunosuppressant properties, treatment for patients with the hemolytic-uremic syndrome, treatment of Lymphangioleiomyomatosis, coronary stent coating, treatment of tuberous sclerosis complex, treatment of Alzheimer’s disease and treatment of muscular dystrophy.
Dr. Mikhail Blagosklonny received his medical doctorate degree in internal medicine from the First Pavlov State Medical University of St. Petersburg. He also received a doctorate in experimental medicine and cardiology from the same university. Later he became an associate professor of medicine at New York Medical College in Valhalla, NY. Dr. Blagosklonny left that position a few years later to become a senior scientist at Ordway Research Institute. In 2009, Dr. Blagosklonny became a professor of oncology at Roswell Park Cancer Institute. He held that position until 2016.
Today, Dr. Blagosklonny is the foremost advocate for using cancer drugs for anti-aging treatment. The Oncologist’s tireless work has impacted thousands of people with the hope that millions can find an affordable and effective treatment for both cancer and diseases related to aging. Know more about Mikhail at Philly Purge.